Samsung BioLogics scores certification from US FDA, EMA
Sept 7, 2016
Samsung BioLogics, a contract manufacturer of biologic drugs under South Korean electronics giant Samsung Group, said Wednesday that it has obtained six manufacturing certifications for biologic drugs produced at its first plant in Songdo, Incheon. Three monoclonal antibody drugs manufactured by Samsung BioLogics on behalf of its two clients Roche and Bristol-Myers Squibb were approved by the European Medicines Agency in July, the Korean biopharma CMO said. Of the three products, two were newly